| Lee, Jin Soo |
NCT06113198 / 2023-000764-58: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age |
|
|
| Recruiting | 4 | 50 | RoW | rMenB+OMV NZ | GlaxoSmithKline, GlaxoSmithKline Biologicals SA | Meningitis, Meningococcal | 04/26 | 09/26 | | |
| Recruiting | 4 | 3944 | RoW | aspirin, clopidogrel, prasugrel, ticagrelor | Asan Medical Center | Coronary Artery Disease | 08/27 | 12/28 | | |
Aladdin, NCT04618640: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years |
|
|
| Recruiting | 3 | 249 | RoW | DTaP-IPV combination vaccine | Boryung Biopharma Co., Ltd. | Diphtheria, Tetanus, Pertussis, Poliomyelitis | 12/20 | 07/21 | | |
| Recruiting | 3 | 778 | Europe, Canada, Japan, US, RoW | Mirikizumab, LY3074828 | Eli Lilly and Company | Crohn's Disease | 11/24 | 12/26 | | |
NCT06346184: A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers |
|
|
| Completed | 1 | 37 | RoW | HCP2303, RLD2302, RLD2102 | Hanmi Pharmaceutical Company Limited | Healthy | 06/24 | 06/24 | | |
HM-EMMA-102, NCT06357910: A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions |
|
|
| Completed | 1 | 34 | RoW | HCP2303, RLD2302, RLD2102 | Hanmi Pharmaceutical Company Limited | Healthy | 07/24 | 07/24 | | |
NCT06518122: A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers |
|
|
| Not yet recruiting | 1 | 60 | RoW | HCP1306, RLD2302, RLD2102 | Hanmi Pharmaceutical Company Limited | Healthy | 01/25 | 01/25 | | |
| Kim, Ki Hwan |
Aladdin, NCT04618640: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years |
|
|
| Recruiting | 3 | 249 | RoW | DTaP-IPV combination vaccine | Boryung Biopharma Co., Ltd. | Diphtheria, Tetanus, Pertussis, Poliomyelitis | 12/20 | 07/21 | | |
NCT04659070: To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia |
|
|
| Recruiting | 3 | 156 | RoW | Experimental : Ezetimibe / Rosuvastatin + Telmisartan, Active comparator1 : Ezetimibe / Rosuvastatin, Active comparator2 : Telmisartan | Hanlim Pharm. Co., Ltd. | Primary Hypercholesterolemia, Hypertension | 05/22 | 05/22 | | |
ENVISION, NCT05310071: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease |
|
|
| Terminated | 3 | 1027 | Europe, Canada, Japan, US, RoW | Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo | Biogen | Alzheimer's Disease | 08/24 | 08/24 | | |
NCT05067634 / 2020-005344-27: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures |
|
|
| Recruiting | 3 | 140 | Europe, US, RoW | Xcopri | SK Life Science, Inc. | Partial Epilepsy | 05/26 | 07/26 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT04903314: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures |
|
|
| Recruiting | 1 | 24 | US, RoW | Xcopri | SK Life Science, Inc. | Partial Epilepsy | 07/24 | 10/24 | | |
NCT05915273: Relapse and Failure Rates Between CAD/CAM and Conventional Fixed Retainers |
|
|
| Completed | N/A | 43 | US | Computer Aided Design/ Computer Aided Manufacturing Retainers, CAD/CAM, Lab-based Retainers, Chairside Retainers | Nourhan M.Aly | Relapse | 09/22 | 09/22 | | |
NCT05609071: Technology of Intracranial Pressure Estimation by Single-Channel EEG in Brain Disease |
|
|
| Active, not recruiting | N/A | 10 | RoW | | Seoul National University Hospital | Intracranial Pressure Increase, Brain Diseases | 02/23 | 12/24 | | |
NCT04952090: Development of Consciousness Measure and Monitor Device Based on Electroencephalography |
|
|
| Recruiting | N/A | 300 | RoW | | Seoul National University Hospital, National Research Foundation of Korea | Electroencephalography, Consciousness | 02/25 | 02/25 | | |
| Bae, Jae Moon |
| Recruiting | 4 | 3944 | RoW | aspirin, clopidogrel, prasugrel, ticagrelor | Asan Medical Center | Coronary Artery Disease | 08/27 | 12/28 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions |
|
|
| Recruiting | N/A | 4000 | RoW | antegrade and retrograde approach | Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical | Chronic Total Occlusion of Coronary Artery | 12/27 | 12/27 | | |
